Mast Cell Tryptase and Asthma
Author Information
Author(s): M-Q. Zhang, H. Timmerman
Primary Institution: Leiden/Amsterdam Centre for Drug Research, Vrije Universiteit
Hypothesis
Tryptase plays a significant role in the pathogenesis of asthma and may be a target for anti-asthmatic therapies.
Conclusion
Tryptase is implicated in asthma through its ability to potentiate bronchoconstriction and promote inflammation.
Supporting Evidence
- Tryptase levels in asthmatic patients are significantly higher than those in normal subjects.
- Allergen challenge in atopic subjects caused an elevation in tryptase levels in bronchoalveolar lavage fluid.
- Tryptase is implicated in adenosine-induced bronchoconstriction.
- Tryptase has been shown to be a potent mitogen for airway smooth muscle cells.
- Inhibition of tryptase can block antigen-induced bronchoconstriction and inflammatory responses.
Takeaway
Tryptase is a protein released by mast cells that can make asthma worse by causing the airways to tighten and become inflamed.
Methodology
The review summarizes experimental data on the role of tryptase in asthma and discusses the effects of tryptase inhibition in animal models.
Limitations
The review primarily discusses animal studies and may not fully translate to human conditions.
Participant Demographics
The study includes data from asthmatic patients and animal models.
Statistical Information
P-Value
P < 0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website